Lu Li
Stock Analyst at UBS
(3.07)
# 2,579
Out of 4,517 analysts
26
Total ratings
80%
Success rate
14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Rated: Hold | $17 → $12 | $18.24 | -34.21% | 7 | May 7, 2026 | |
| WAT Waters | Maintained: Hold | $330 → $375 | $378.19 | -0.84% | 2 | May 6, 2026 | |
| VCYT Veracyte | Maintained: Buy | $48 → $52 | $59.22 | -12.19% | 6 | May 6, 2026 | |
| DHR Danaher | Maintained: Buy | $250 | $205.01 | +21.95% | 1 | Apr 22, 2026 | |
| FLGT Fulgent Genetics | Maintained: Buy | $35 → $22 | $20.55 | +7.06% | 3 | Mar 2, 2026 | |
| MYGN Myriad Genetics | Maintained: Hold | $8 → $6 | $6.19 | -3.07% | 7 | Feb 25, 2026 |
QuidelOrtho
May 7, 2026
Rated: Hold
Price Target: $17 → $12
Current: $18.24
Upside: -34.21%
Waters
May 6, 2026
Maintained: Hold
Price Target: $330 → $375
Current: $378.19
Upside: -0.84%
Veracyte
May 6, 2026
Maintained: Buy
Price Target: $48 → $52
Current: $59.22
Upside: -12.19%
Danaher
Apr 22, 2026
Maintained: Buy
Price Target: $250
Current: $205.01
Upside: +21.95%
Fulgent Genetics
Mar 2, 2026
Maintained: Buy
Price Target: $35 → $22
Current: $20.55
Upside: +7.06%
Myriad Genetics
Feb 25, 2026
Maintained: Hold
Price Target: $8 → $6
Current: $6.19
Upside: -3.07%